Further consolidation in the Chinese orthopedics market

On January 17, 2013, Stryker, a leading medical device company based in Michigan, announced that it is acquiring Trauson Holdings, a Chinese orthopedic company publicly traded on the Hong Kong stock exchange. Stryker’s offer of HK$7.5 per share in cash, for a transaction value of $764 million, is a ...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Livekindly Collective closes $335 million funding round for its plant-based platform, bringing total funding to $535 million

News Commentary | March 31, 2021

The $335 million is inclusive of the $135 million it raised in October 2020. The Rise Fund led the round, with other notable investors including Rabo Corporate Investments, the investment arm of Rabobank, and S2G Ventures. Livekindly Collective intends to use the funding for continued market ... To read more, click here.

Modern Meadow raises whopping $130 million Series C despite lack of progress

News Commentary | May 05, 2021

Modern Meadow has repeatedly overhyped its technology, setting expectations high and then failing to deliver despite its large previous capital and support from large industry players like Evonik. Now, Andras Forgacs is stepping down as CEO, and the company is shifting its first product launch to a ... To read more, click here.

DSM reorganizes around Health, Nutrition & Bioscience business

News Commentary | September 16, 2021

DSM has already been investing heavily in this space and sold its resins business to Covestro, so this move follows an established pattern. It's clear that DSM views its health‑focused business as greener pastures than materials and chemicals for both growth and sustainability. Clients should expect... Not part of subscription